Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Meier

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of the Endocrine Society|October 22, 2024
Ablation of PC1/3 in POMC-Expressing Tissues but Not in Immune Cells Induces Sepsis HypersensitivityJana Moeller, Daniel T Meier
Seminars in Immunopathology|April 17, 2019
Islet inflammation in type 2 diabetesMarianne Böni-Schnetzler, Daniel T Meier
Endocrine Reviews|May 26, 2019
Inflammation in the Pathophysiology and Therapy of Cardiometabolic DiseaseMarc Y Donath, Daniel T Meier, Marianne Böni-Schnetzler
Diabetologia|November 4, 2024
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesityDaniel T Meier, Joyce de Paula Souza, Marc Y Donath
Immunity|January 12, 2022
Inflammation in obesity, diabetes, and related disordersTheresa V Rohm, Daniel T Meier, Jerrold M Olefsky, et al.
Plos One|October 4, 2023
Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine productionAxel de Baat, Daniel T Meier, Adriano Fontana, et al.
STAR Protocols|October 27, 2023
Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreasLaura Steiger, Zora Baumann, Lena Keller, et al.
Diabetologia|June 27, 2014
Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic miceDaniel T Meier, Mary Morcos, Thanya Samarasekera, et al.
Diabetologia|August 31, 2023
Cystine/glutamate antiporter System x<sub>c</sub><sup>-</sup> deficiency impairs insulin secretion in miceAxel de Baat, Daniel T Meier, Leila Rachid, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 6, 2013
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in miceKathryn Aston-Mourney, Shoba L Subramanian, Sakeneh Zraika, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of the Endocrine Society|October 22, 2024
Ablation of PC1/3 in POMC-Expressing Tissues but Not in Immune Cells Induces Sepsis HypersensitivityJana Moeller, Daniel T Meier
Seminars in Immunopathology|April 17, 2019
Islet inflammation in type 2 diabetesMarianne Böni-Schnetzler, Daniel T Meier
Endocrine Reviews|May 26, 2019
Inflammation in the Pathophysiology and Therapy of Cardiometabolic DiseaseMarc Y Donath, Daniel T Meier, Marianne Böni-Schnetzler
Diabetologia|November 4, 2024
Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesityDaniel T Meier, Joyce de Paula Souza, Marc Y Donath
Immunity|January 12, 2022
Inflammation in obesity, diabetes, and related disordersTheresa V Rohm, Daniel T Meier, Jerrold M Olefsky, et al.
Plos One|October 4, 2023
Cystine/Glutamate antiporter system xc- deficiency impairs macrophage glutathione metabolism and cytokine productionAxel de Baat, Daniel T Meier, Adriano Fontana, et al.
STAR Protocols|October 27, 2023
Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreasLaura Steiger, Zora Baumann, Lena Keller, et al.
Diabetologia|June 27, 2014
Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic miceDaniel T Meier, Mary Morcos, Thanya Samarasekera, et al.
Diabetologia|August 31, 2023
Cystine/glutamate antiporter System x<sub>c</sub><sup>-</sup> deficiency impairs insulin secretion in miceAxel de Baat, Daniel T Meier, Leila Rachid, et al.
American Journal of Physiology. Endocrinology and Metabolism|June 6, 2013
One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in miceKathryn Aston-Mourney, Shoba L Subramanian, Sakeneh Zraika, et al.
Pageof 4